TUCSON, Ariz. , April 27, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will report its financial results for the quarter ended March 31, 2018 after the market …
Meet us in Montpellier, France at the 11th ISMRC Conference May 3 - 5 at The Corum Conference Centre
Mr. Lubniewski assumes the role after having served for seven years as Chief Business Officer TUCSON, Ariz. , April 16, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the …
HTG’s 1:1 Promise Cdx Partnerships, Personalized.
HTG will be at the 2018 ASCO Annual Meeting. Stop by and learn how our NGS-based HTG EdgeSeq chemistry and automation can help shape the future of oncology.
McCormick Place | Chicago, IL | June 1 - June 5 | Booth #4113 | Meeting Room MR1 on Exhibit Hall Floor
Join us Tuesday, May 29, for a webinar with Dr. Richard Myers, Director, Genome Science Institute Boston University School of Medicine.
Open event page and learn more about our customer posters to be presented at this year’s AACR Conference and be sure to stop by booth 4008 for an HTG EdgeSeq instrumentation demo. See you in a few weeks!
"The HTG EdgeSeq technology represents a nice way to combine the possibility of working with FFPE specimens and next-generation approaches. Moreover, the HTG EdgeSeq Oncology Biomarker Panel (OBP) can be applied on in vitro models and then the results can be validated on FFPE specimens from clinical studies using the same assay." Dr. Bertoni, MD
Patent covers nuclease protection methods for detection of nucleotide variants TUCSON, Ariz. , April 03, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the issuance of …
TUCSON, Ariz. , March 27, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications today announced that it has entered into a senior debt facility with MidCap Financial (MidCap), a healthcare …
Revenue increased 442% and 188%, respectively, compared to the three and twelve month periods in the prior year driven by development efforts supporting Pharma clinical programs TUCSON, Ariz. , March 22, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc….
TUCSON, Ariz. , March 07, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will report its financial results for the quarter and year ended December 31, 2017 after…
Patent covers methods of co-detecting mRNA and small non-coding RNA TUCSON, Ariz. , Feb. 26, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the issuance of Australian…
Page last updated March 20, 2023